Diuretics should continue to be one of the preferred initial therapies in the management of hypertension: the argument for.
作者信息
Moser Marvin
机构信息
Yale University School of Medicine, New Haven, CT, USA.
出版信息
J Clin Hypertens (Greenwich). 2005 Feb;7(2):111-6; quiz 121-2. doi: 10.1111/j.1524-6175.2005.03943.x.
Abstract
摘要
相似文献
1
Diuretics should continue to be one of the preferred initial therapies in the management of hypertension: the argument for.利尿剂应继续作为高血压管理中首选的初始治疗方法之一：支持该观点的理由。
J Clin Hypertens (Greenwich). 2005 Feb;7(2):111-6; quiz 121-2. doi: 10.1111/j.1524-6175.2005.03943.x.
2
Diuretics should continue to be one of the preferred initial therapies in the management of hypertension: the argument against.利尿剂不应继续作为高血压管理的首选初始治疗方法之一：反对观点。
J Clin Hypertens (Greenwich). 2005 Feb;7(2):117-20; quiz 121-2.
3
Mild hypertension, diuretics, and cardiac arrhythmias: consensus amid controversy?轻度高血压、利尿剂与心律失常：争议中的共识？
Am Heart J. 1988 Jul;116(1 Pt 1):216-21. doi: 10.1016/0002-8703(88)90279-7.
4
The cardiovascular risks of thiazide diuretics.噻嗪类利尿剂的心血管风险。
Clin Pharmacol Ther. 1986 Mar;39(3):239-44. doi: 10.1038/clpt.1986.33.
5
[Dyslipidemia and thiazide diuretics].[血脂异常与噻嗪类利尿剂]
Nihon Rinsho. 2001 Mar;59 Suppl 3:223-6.
6
[Diuretics and loss of potassium].[利尿剂与钾流失]
Schweiz Med Wochenschr. 1978 Sep 30;108(39):1513-4.
7
Diuretics in the management of hypertension.利尿剂在高血压治疗中的应用
Postgrad Med. 1982 Feb;71(2):155-9, 162-8. doi: 10.1080/00325481.1982.11715994.
8
Hypokalaemia induced by thiazide diuretics in the treatment of hypertension: a cause for concern, not nihilism.噻嗪类利尿剂治疗高血压时引起的低钾血症：值得关注，而非虚无主义。
Postgrad Med J. 1983;59 Suppl 3:137-9.
9
Effect of potassium depletion by thiazides.噻嗪类药物所致钾缺乏的影响。
Arch Intern Med. 1988 Jun;148(6):1265-6.
10
Diuretic-induced cardiac arrhythmias.利尿剂诱发的心律失常。
Md State Med J. 1983 Dec;32(12):903-4.
引用本文的文献
1
Fixed-dose combinations as initial therapy for hypertension: a review of approved agents and a guide to patient selection.固定剂量复方制剂作为高血压初始治疗药物：已批准药物的综述及患者选择指南。
Drugs. 2009;69(13):1761-76. doi: 10.2165/11316710-000000000-00000.
2
Thiazide effects and adverse effects: insights from molecular genetics.噻嗪类药物的作用与不良反应：分子遗传学的见解
Hypertension. 2009 Aug;54(2):196-202. doi: 10.1161/HYPERTENSIONAHA.109.129171. Epub 2009 Jun 29.
3
Development of diabetes with thiazide diuretics: the potassium issue.噻嗪类利尿剂与糖尿病的发生：钾的问题。
J Clin Hypertens (Greenwich). 2005 Nov;7(11):638-40. doi: 10.1111/j.1524-6175.2005.04144.x.
本文引用的文献
1
Continued importance of diuretics and beta-adrenergic blockers in the management of hypertension.利尿剂和β-肾上腺素能阻滞剂在高血压管理中的持续重要性。
Med Clin North Am. 2004 Jan;88(1):167-87. doi: 10.1016/s0025-7125(03)00121-4.
2
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.钙拮抗剂与非钙拮抗剂治疗冠心病患者高血压的策略。国际维拉帕米-群多普利研究（INVEST）：一项随机对照试验。
JAMA. 2003 Dec 3;290(21):2805-16. doi: 10.1001/jama.290.21.2805.
3
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.坎地沙坦对正在服用血管紧张素转换酶抑制剂的慢性心力衰竭且左心室收缩功能降低患者的影响：CHARM-Added试验
Lancet. 2003 Sep 6;362(9386):767-71. doi: 10.1016/S0140-6736(03)14283-3.
4
Chlorothiazide as an adjunct in the treatment of essential hypertension.氯噻嗪作为治疗原发性高血压的辅助药物。
Am J Cardiol. 1959 Feb;3(2):214-9. doi: 10.1016/0002-9149(59)90289-9.
5
Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).新诊断高血压患者1年的代谢转归：瑞典北部抗高血压治疗与血脂状况疗效评估（ALPINE研究）结果
J Hypertens. 2003 Aug;21(8):1563-74. doi: 10.1097/01.hjh.0000084723.53355.76.
6
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.美国国家高血压预防、检测、评估与治疗联合委员会第七次报告：JNC 7报告。
JAMA. 2003 May 21;289(19):2560-72. doi: 10.1001/jama.289.19.2560. Epub 2003 May 14.
7
The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.老年人认知与预后研究（SCOPE）：一项随机双盲干预试验的主要结果
J Hypertens. 2003 May;21(5):875-86. doi: 10.1097/00004872-200305000-00011.
8
A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.老年高血压患者使用血管紧张素转换酶抑制剂和利尿剂的疗效比较。
N Engl J Med. 2003 Feb 13;348(7):583-92. doi: 10.1056/NEJMoa021716.
9
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).高危高血压患者随机接受血管紧张素转换酶抑制剂或钙通道阻滞剂与利尿剂治疗的主要结局：抗高血压和降脂治疗预防心脏病发作试验（ALLHAT）
JAMA. 2002 Dec 18;288(23):2981-97. doi: 10.1001/jama.288.23.2981.
10
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.氯沙坦干预降低高血压终点事件研究（LIFE）中的心血管发病率和死亡率：一项与阿替洛尔对比的随机试验。
Lancet. 2002 Mar 23;359(9311):995-1003. doi: 10.1016/S0140-6736(02)08089-3.
Zotero 插件